BioNTech's Q1 Vaccine Sales Triple But It Still Flags Full-year Decline

BioNTech’s Q1 Vaccine Sales Triple But It Still Flags Full-year Decline

FRANKFURT (Reuters) -BioNTech’s first-quarter sales and earnings more than tripled thanks to demand for the COVID-19 vaccine it developed with Pfizer, but the German biotech firm is still forecasting a full-year decline in vaccine sales. Quarterly revenues more than tripled from a year earlier to 6.37 billion euros ($6.73 billion), as did net income, to 3.70 billion…

Read More
Brazil Watchdog Proposes Approval Of Pague Menos Buy Of Extrafarma

Brazil Watchdog Proposes Approval Of Pague Menos Buy Of Extrafarma

SAO PAULO (Reuters) – The technical body of Brazilian antitrust watchdog Cade has recommended the approval of the acquisition of pharmacy chain Extrafarma by rival Pague Menos, the company said on Monday. Cade’s technical body has recommended that Extrafarma sells around 3% of its stores to eliminate competition concerns, the company added. The agreement needs…

Read More